FLT3 and acute myeloid leukemia: The internal tandem duplication (ITD) mutations of FMS-like tyrosine kinase 3 (FLT3) occur in approximately 25% of acute myeloid leukemia (AML) cases and are associated with poor therapeutic efficacy and short survival 1.